
This event will take place on November 13 – 15, 2014, in San Francisco California.
Synbiobeta will engage a conversation on sector-specific progress ranging from research-enabling tools to low-cost DNA synthesis, scale-up of industrial biotech platforms to the growing importance of the organism industry.
Who Should Attend?
Startups: Meet the investors ready to fund your team.
Industry: Network with industry leaders and potential partners.
Investors: Meet the new startups on the scene.
Partners & Tech Scouts: Learn about the latest technology in the field.
Academics, Students & Biohackers: Follow the path to commercializing your IP.
Speakers
J. Craig Venter
Spencer Adler
SynBio Investors
Omri Amirav-Drory
Genome Compiler
Jamie Bacher
Pareto Biotechnologies
Justin Bingham
SGI-DNA
Mark Bünger
Lux Research
Blake Byers
Google Ventures
Rob Carlson
Biodesic
Brandon Chen
Genomatica
Elizabeth Clarke
Industrial Microbes
Adam Clore
Integrated DNA Technologies
Denver Dale
On-Point Capital
Stephen del Cardayre
Douglas Densmore
Lattice Automation
Jeffrey Dietrich
Lygos
Tim Fell
Synthace
Michael Fero
TeselaGen
Ian Fotheringham
Ingenza
Itschak Friedman
LionBird
Edward Green
Green Biologics Ltd
Eli Groban
Intrexon
Claes Gustafsson
DNA2.0
Rachel E. Haurwitz
Caribou Biosciences
Keira Havens
Revolution Bioengineering
Austen Heinz
Cambrian Genomics
Alfred Ho
Morph Bioinformatics
Max Hodak
Transcriptic
Jeffrey Hung
GenScript
Elizabeth Iorns
Science Exchange
Jason Kakoyiannis
Bioscentric
Kef Kasdin
Proterro
Michael Koepke
LanzaTech
Mike Koeris
Sample6
Devin Leake
Gen9
Scott Nolan
Founders Fund
Matt Ocko
Data Collective
Jonny Ohlson
Touchlight Genetics
Christian Olsen
Biomatters
Megan Palmer
Synberc
Una Ryan
Bay Area BioEconomy Initiative
Zach Serber
Zymergen
Reshma Shetty
Ginkgo BioWorks
Steve Somers
Vigon International
Sajith Wickramasekara
Benchling
Dan Widmaier
Refactored Materials
Michael Yates
Algenuity
To register click here.
Discover more from Change Oracle
Subscribe to get the latest posts sent to your email.






